Think you’ve squeezed the maximum weight and cycle time out of your injection-molded design? Users of MuCell microcellular-foam technology beg to differ. They’ve cut part weight 8 to 12% without major ...
The U.S. FDA approved Merck & Co. Inc.’s Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection on Sept. 19, making it the first and only subcutaneously (SC)-administered immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback